← HUTCHMED (China) Ltd
| Annual Trend | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $216.1m |
$241.2m
+11.63%
|
$214.1m
-11.23%
|
$204.9m
-4.31%
|
$228.0m
+11.27%
|
$356.1m
+56.21%
|
$426.4m
+19.73%
|
$838.0m
+96.52%
|
$630.2m
-24.80%
|
$548.5m
-12.96%
|
$548.5m
0.00%
|
|
| Cost of Revenue | $149.1m |
$169.8m
+13.83%
|
($15.6m)
-109.17%
|
($13.4m)
+14.05%
|
($13.9m)
-4.16%
|
($10.7m)
+23.51%
|
($7.9m)
+25.55%
|
($5.7m)
+27.76%
|
$348.9m
+6185.54%
|
$336.3m
-3.59%
|
$336.3m
0.00%
|
|
| Cost of goods and services | ($15.2m) |
($21.2m)
-39.48%
|
($15.6m)
+26.69%
|
($13.4m)
+14.05%
|
($13.9m)
-4.16%
|
($10.7m)
+23.51%
|
($7.9m)
+25.55%
|
($5.7m)
+27.76%
|
($348.9m)
-5985.54%
|
($336.3m)
+3.59%
|
$336.3m
+200.00%
|
|
| Gross Profit (Calculated) (derived) | $66.9m |
$71.4m
+6.71%
|
$198.5m
+177.92%
|
$191.5m
-3.54%
|
$214.0m
+11.76%
|
$345.5m
+61.40%
|
$418.5m
+21.13%
|
$832.3m
+98.88%
|
$281.3m
-66.20%
|
$212.2m
-24.58%
|
— | |
| Research and Development Expense | $66.9m | $75.5m | $114.2m | $138.2m | $174.8m | $299.1m | $386.9m | $302.0m | $212.1m | $148.3m | $148.3m | |
| General and Administrative Expense | $21.6m | $24.0m | $30.9m | $39.2m | $50.0m | $89.3m | $92.2m | $79.8m | $64.3m | $66.7m | $66.7m | |
| Labor and Related Expense | — | $24.8m | $35.3m | $46.2m | $63.5m | $91.6m | $119.3m | $93.0m | $69.1m | $58.3m | — | |
| Operating Lease, Expense | — | — | — | $4.0m | $3.7m | $4.4m | $5.4m | — | — | — | — | |
| Operating Expenses | $262.8m | $294.6m | $306.8m | $351.3m | $424.6m | $684.4m | $834.1m | $819.6m | $673.9m | $587.7m | $584.2m | |
| Operating Income (Loss) | ($46.7m) |
($53.4m)
-14.39%
|
($92.6m)
-73.43%
|
($146.4m)
-58.01%
|
($196.7m)
-34.35%
|
($328.3m)
-66.94%
|
($407.7m)
-24.18%
|
$18.4m
+104.51%
|
($43.7m)
-337.85%
|
($39.2m)
+10.40%
|
($35.7m)
+8.84%
|
|
| Interest income | $502k | $1.2m | $6.0m | $4.9m | $3.2m | $2.1m | $9.6m | $36.1m | $40.1m | $49.9m | $49.9m | |
| Other Nonoperating Income (Expense) | ($139k) | — | — | — | — | — | — | — | — | — | — | |
| Income (Loss) from Equity Method Investments | $66.2m | $33.7m | $19.3m | $40.7m | $79.0m | $60.6m | $49.8m | $47.3m | $46.5m | $22.7m | — | |
| Other income | $609k | $808k | $1.8m | $1.9m | $4.6m | $2.4m | $1.8m | $12.9m | $10.3m | $19.7m | — | |
| Other expense | ($139k) | ($692k) | ($781k) | ($488k) | ($115k) | ($12.6m) | ($13.5m) | ($8.4m) | ($4.9m) | ($5.8m) | — | |
| Interest Expense (non-operating) | $1.6m | $1.5m | $1.0m | $1.0m | $787k | $592k | $652k | $759k | $2.9m | $2.9m | $2.9m | |
| Total other income/(expense) | ($659k) | ($119k) | $6.0m | $5.3m | $6.9m | ($8.7m) | ($2.7m) | $39.9m | $42.6m | $61.0m | — | |
| Income/(loss) before income taxes and equity in earnings of equity investees | ($47.4m) | ($53.5m) | ($86.7m) | ($141.1m) | ($189.7m) | ($215.7m) | ($410.4m) | $58.3m | ($1.1m) | $498.7m | — | |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | $20.5m | — | — | — | — | — | — | — | — | — | $498.7m | |
| Current Income Tax Expense (Benefit) | — | $1.4m | $2.0m | $1.7m | $1.5m | $16.6m | $3.3m | $2.3m | $1.9m | $63.7m | $63.6m | |
| Income Tax Expense (Benefit) | $4.3m | $3.1m | $4.0m | $3.3m | $4.8m | $11.9m | ($283k) | $4.5m | $7.2m | $63.6m | $63.6m | |
| Less: Net income attributable to non-controlling interests | ($2.9m) | ($3.8m) | ($3.5m) | ($2.3m) | ($10.2m) | ($27.6m) | ($449k) | ($314k) | ($441k) | ($823k) | — | |
| Net Income (Loss) Attributable to Parent | $11.7m |
($26.7m)
-328.56%
|
($74.8m)
-179.78%
|
($106.0m)
-41.73%
|
($125.7m)
-18.59%
|
($194.6m)
-54.81%
|
($360.8m)
-85.38%
|
$100.8m
+127.93%
|
$37.7m
-62.56%
|
$456.9m
+1111.03%
|
$456.9m
0.00%
|
|
| Net Income (Loss) Available to Common Stockholders, Basic | $11.7m |
($26.7m)
-328.56%
|
($71.3m)
-166.62%
|
($103.7m)
-45.44%
|
($115.5m)
-11.42%
|
($167.0m)
-44.60%
|
($360.4m)
-115.75%
|
$100.8m
+127.96%
|
$37.7m
-62.56%
|
$456.9m
+1111.03%
|
$456.9m
0.00%
|
|
| Net Income (Loss) Attributable to Noncontrolling Interest | $2.9m | $3.8m | $3.5m | $2.3m | $10.2m | $27.6m | $449k | $314k | $441k | $823k | $456.9m | |
| Income (Loss) from Continuing Operations, Per Basic Share | $0 | — | — | — | — | — | — | — | — | — | — | |
| Income (Loss) from Continuing Operations, Per Diluted Share | $0 | — | — | — | — | — | — | — | — | — | — | |
| Earnings Per Share, Basic | $0.20 | ($0.43) | ($1.13) | ($0.16) | ($0.18) | ($0.25) | ($0.43) | $0.12 | $0.04 | $0.53 | $0.10 | |
| Earnings Per Share, Diluted | $0.20 | ($0.43) | ($1.13) | — | — | ($0.25) | ($0.43) | $0.12 | $0.04 | $0.52 | $0.10 | |
| Weighted Average Number of Shares Outstanding, Basic | 59.7m | 61.7m | 66.4m | 665.7m | 697.9m | 792.7m | 847.1m | 849.7m | 855.4m | 858.3m | 172.5m | |
| Weighted Average Number of Shares Outstanding, Diluted | 60.0m | 61.7m | 66.4m | — | — | 792.7m | 847.1m | 869.2m | 872.8m | 872.9m | 174.6m | |
| Additional Financial Items | ||||||||||||
| (Loss)/income from operations | ($46.7m) | ($53.4m) | ($92.6m) | ($146.4m) | ($196.7m) | ($328.3m) | ($407.7m) | $18.4m | ($43.7m) | ($39.2m) | — | |
| Costs and Expenses | $262.8m | $294.6m | $306.8m | $351.3m | $424.6m | $684.4m | $834.1m | $819.6m | $673.9m | $587.7m | — | |
| Goodwill, Impairment Loss | $0 | $0 | — | — | — | — | — | — | — | — | $89k | |
| Selling Expense | $18.0m | $19.3m | $17.7m | $13.7m | $11.3m | $37.8m | $43.9m | $53.4m | $48.6m | $36.3m | — | |
| Gain on divestment of an equity investee | — | — | — | — | — | $121.3m | — | — | — | $476.9m | — | |
| Equity in earnings of equity investees, net of tax | $66.2m | $33.7m | $19.3m | $40.7m | $79.0m | $60.6m | $49.8m | $47.3m | $46.5m | $22.7m | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | $11.7m | — | — | — | — | — | — | — | — | — | — | |
| Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest | $14.6m | — | — | — | — | — | — | — | — | — | — |